| Name | Title | Contact Details |
|---|
BeWellNM has established its online communities to serve as informative and engaging resources for the public. Our goal is to facilitate a constructive, open dialogue around the Patient Protection and Affordable Care Act, and to answer questions relate...
Mercy Health System is the largest Catholic healthcare system serving the Delaware Valley and is a member of Catholic Health East, a multi-institutional, Catholic health system co-sponsored by 13 religious congregations and Hope Ministries.
Illinois State Medical Society is a Chicago, IL-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
BrightCoach is a rapidly growing innovator in the Coaching industry. It is a company of talented, experienced, executive business, and life coaches, dedicated to enriching lives and helping our clients achieve their desired goals. BrightCoach works closely with our clients to help them move forward in a unique one-on-one Coaching relationship to create positive change, leadership skills, active self-discovery and extraordinary results in their lives, careers, businesses or organizations. BrightCoach has developed a unique Coaching methodology combining today’s latest science of change within structured, personalized Coaching programs, to help our clients move from where they are - to where they want to be.
Kite Pharma, founded in 2009, is dedicated to the development and commercialization of novel cancer immunotherapy products designed to harness the power of a patient’s own immune system to fight tumor cells. Kite’s lead programs are in collaboration with the National Cancer Institute (NCI) and are being studied through the NCI’s Surgery Branch led by Steven A. Rosenberg, MD, PhD, who has pioneered immunotherapy approaches for cancer for more than two decades. This research has resulted in breakthrough clinical findings, including results from an NCI Phase 1/2a trial being presented at this year’s American Society of Hematology (ASH) Annual Meeting. Based on this progress and momentum, Kite plans to initiate a company-sponsored multicenter clinical program in aggressive non-Hodgkin’s lymphoma, with additional filings expected for other eACT™ products in diverse oncology indications.